Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Compliance differences between patients with breast cancer in university and county hospitals.

Komenaka IK, Pennington RE Jr, Schneider BP, Hsu CH, Norton LE, Clare SE, Zork NM, Goulet RJ Jr.

Clin Breast Cancer. 2010 Oct 1;10(5):385-91. doi: 10.3816/CBC.2010.n.051.

PMID:
20920983
2.

Preoperative chemotherapy for operable breast cancer is associated with better compliance with adjuvant therapy in matched stage II and IIIA patients.

Komenaka IK, Hsu CH, Martinez ME, Bouton ME, Low BG, Salganick JA, Nodora J, Hibbard ML, Jha C.

Oncologist. 2011;16(6):742-51. doi: 10.1634/theoncologist.2010-0266. Epub 2011 May 9.

3.

Breast conservation therapy in affiliated county, university, and private hospitals.

Heimbach JK, Biffl WL, Mitchell EL, Finlayson CA, Schwartzberg BS, Myers A, Rabinovitch R, Franciose RJ.

Am J Surg. 1999 Dec;178(6):466-9.

PMID:
10670854
4.

Improving local control with breast-conserving therapy: a 27-year single-institution experience.

Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, Babiera GV, Ames FC, Sahin AA, Meric-Bernstam F.

Cancer. 2005 Jul 1;104(1):20-9.

5.

The effect of dedicated breast surgeons on the short-term outcomes in breast cancer.

Zork NM, Komenaka IK, Pennington RE Jr, Bowling MW, Norton LE, Clare SE, Goulet RJ Jr.

Ann Surg. 2008 Aug;248(2):280-5. doi: 10.1097/SLA.0b013e3181784647.

PMID:
18650639
6.

[A population-based study on variations in the use of adjuvant radiotherapy in breast cancer patients].

Nagel G, Röhrig B, Hoyer H, Füller J, Katenkamp D.

Strahlenther Onkol. 2002 Nov;178(11):589-96. German.

PMID:
12426669
7.

Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.

Ishitobi M, Komoike Y, Motomura K, Koyama H, Inaji H.

Breast J. 2010 Jan-Feb;16(1):9-13. doi: 10.1111/j.1524-4741.2009.00864.x. Epub 2009 Nov 19.

PMID:
19929889
8.

Response to the National Cancer Institute Alert. The effect of practice guidelines on two hospitals in the same medical community.

Studnicki J, Schapira DV, Bradham DD, Clark RA, Jarrett A.

Cancer. 1993 Nov 15;72(10):2986-92.

9.

Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.

Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA.

J Clin Oncol. 2004 Dec 1;22(23):4691-9. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

PMID:
15570071
10.

Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Venkatesan V, Dar AR, Stitt L.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):541-50.

PMID:
9231678
11.

Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: a single-institution experience.

Barbieri V, Sanpaolo P, Genovesi D.

Clin Breast Cancer. 2011 Apr;11(2):114-20. doi: 10.1016/j.clbc.2011.03.004. Epub 2011 Apr 11.

PMID:
21569997
12.

Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.

Pass H, Vicini FA, Kestin LL, Goldstein NS, Decker D, Pettinga J, Ingold J, Benitez P, Neumann K, Rebner M, Dekhne N, Martinez A.

Cancer. 2004 Aug 15;101(4):713-20.

13.

Breast cancer treatment guidelines in older women.

Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML.

J Clin Oncol. 2005 Feb 1;23(4):783-91.

PMID:
15681522
14.

Race and ethnicity and breast cancer outcomes in an underinsured population.

Komenaka IK, Martinez ME, Pennington RE Jr, Hsu CH, Clare SE, Thompson PA, Murphy C, Zork NM, Goulet RJ Jr.

J Natl Cancer Inst. 2010 Aug 4;102(15):1178-87. doi: 10.1093/jnci/djq215. Epub 2010 Jun 23.

PMID:
20574040
15.
16.

High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial.

Fontein DB, Nortier JW, Liefers GJ, Putter H, Meershoek-Klein Kranenbarg E, van den Bosch J, Maartense E, Rutgers EJ, van de Velde CJ.

Eur J Surg Oncol. 2012 Feb;38(2):110-7. doi: 10.1016/j.ejso.2011.11.010. Epub 2011 Dec 14.

17.

Are many community hospitals undertreating breast cancer?: lessons from 24,834 patients.

Gutierrez JC, Hurley JD, Housri N, Perez EA, Byrne MM, Koniaris LG.

Ann Surg. 2008 Aug;248(2):154-62. doi: 10.1097/SLA.0b013e31816c4030.

PMID:
18650623
18.

Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.

Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):351-7.

PMID:
15890574
19.

Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.

Touboul E, Buffat L, Lefranc JP, Blondon J, Deniaud E, Mammar H, Laugier A, Schlienger M.

Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):1019-28.

PMID:
8600084
20.

Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in Japan.

Horiguchi J, Iino Y, Koibuchi Y, Yokoe T, Takei H, Yamakawa M, Nakajima T, Oyama T, Ando T, Ishida T, Endo K, Takai Y, Suzuki H, Fujii T, Yokomori T, Morishita Y.

Breast Cancer. 2002;9(2):160-5.

PMID:
12016396

Supplemental Content

Support Center